Blog

11
Feb

What I Learned In A French Lab That Led To My Role As A CEO

Article by Pascal Descargues, first published in Life Science Leader on February 1, 2022. The original article is available here. What I Learned In A French Lab That Led To My Role As CEO The Path to the Aha Moment In 2006, I had just finished my Ph.D. in human pathophysiology, and I was working in a lab in Toulouse,
Read more
3
Jan

Better technology for reliable drug development

Advancing New Approach Methodologies for ethical & reliable drug development New Approach Methodologies: Changing drug development as we know it Drug development is long, expensive, and painfully inefficient. With 90% of drug candidates failing before clinical approval, the industry is desperate for human-relevant, predictive tools—this is where New Approach Methodologies (NAMs) have emerged as a vital solution. At Genoskin, we
Read more
28
Oct

De-risking antiaging trials with ex vivo skin models

Article written by Danny Sullivan and first published in Longevity Technology on October 28th, 2021. The original article is available here. Genoskin can help de-risk antiaging trials with the only live human skin model available for subcutaneous administration testing With its proprietary ex vivo human skin technologies, French partner research organisation Genoskin says it is paving the way to “better,
Read more
15
Jun

Top advantages of ordering NativeSkin access® vs sourcing skin directly from hospitals

Top advantages of ordering NativeSkin access® vs sourcing skin directly from hospitals Interested in trying NativeSkin access®? Do you still think that sourcing skin samples directly from hospitals is the only valid way? Let us change your mind with these top advantages to ordering  NativeSkin access® online! NativeSkin access® is a patented human skin model that makes the culture, treatment,
Read more
22
Feb

Using NativeSkin® to study poison ivy-induced dermatitis

Using NativeSkin® to evaluate poison ivy effects  A couple of months ago, Genoskin’s team started to wonder: “Why not try to better understand poison ivy dermatitis through our NativeSkin® model ?” In this article, we summarize information about what is known regarding the poison ivy reaction and what happens on a macroscopic level when poison ivy toxin is applied to
Read more
30
Nov

Human connective tissue mast cells

Human Peripheral Blood-derived Cultured Mast Cells A cellular model to study injection site reactions & severe allergic reactions. In vitro mast cell culture assays are critical to better understand the kinetics and dynamics underlying inflammatory reactions. Genoskin has developed a method to culture Human Peripheral Blood-derived Cultured Mast Cells (PBCMCs) from healthy individuals. We isolate CD34+ progenitors from PBMCs of
Read more